Associations of lipoproteins with bone mass in postmenopausal women


Cite item

Abstract

Aim. To study an association between blood lipid composition and bone mass in Russian postmenopausal women. Subjects and methods. The cross-sectional study included 373 postmenopausal women aged 45—80 years who were examined to diagnose osteoporosis in outpatient settings. Height, body weight, and waist and hip circumferences (WC and HC) were measured before densitometry. Quetelet’s index was calculated as a ratio of weight (kg) to height (m2). The concentration of lipids and apolipoproteins (apo) AІ and B were measured by enzyme immunoassay. Bone mineral density (BMD) in the spine and proximal femur (PF) was estimated by dual-energy X-ray absorptiometry. Results. According to bone mass, the patients were divided into three groups: 1) osteoporosis (OP); 2) osteopenia; 3) normal BMD. The levels of total cholesterol and high-density lipoprotein (HDL) cholesterol were significantly higher in the postmenopausal women with OP than in those with normal bone mass. There was a negative correlation of cholesterol and HDL cholesterol levels with lumbar spine BMD and that of HDL levels with BMD in the femoral neck (FN) and entire PF. The level of lipoprotein (a) (LPa) was significantly lower in the group of patients with OP and positively correlated with BMD in FN and entire PF. After adjustment for age, the duration of menopause, Quetelet’s index, and WC/HC association remained only between LPa and FN BMD. Conclusion. Multivariate regression analysis failed to confirm a trend towards decreased BMD and increased HDL cholesterol. This suggests that the association of HDL cholesterol with bone mass is apparently mediated by other factors and, above all, with age, postmenopausal hormonal status and body weight.

References

  1. Von der Recke P, Hansen M, Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med. 1999;106(3):273-278. doi: 10.1016/s0002-9343(99)00028-5.
  2. Tanko L, Christiansen C, Cox D, Geiger M, McNabb M, Cummings, S. Relationship between osteoporosis and ardiovascular disease in postmenopausal women. J Bone Miner Res. 2005;20:1912-1920. doi: 10.1359/jbmr.050711.
  3. Sennerby U, Farahmand B, Ahlbom A, Ljunghall S, Michaëlsson K. Cardiovascular diseases and future risk of hip fracture inwomen. Osteoporos Int. 2007;18:1355-1362. doi: 10.1007/s00198-007-0386-0.
  4. Sennerby U, Melhus H, Gedeborg R, Byberg L, Garmo H, Ahlbom A, Pedersen N, Michaëlsson K. Cardiovascular diseases and risk of hip fracture. JAMA. 2009;302:1666-1673. doi: 10.1001/jama.2009.1463.
  5. Hsu Y, Venners S, Terwedow H, Feng Y, Niu T, Li Z, Laird N, Brain J, Cumming S. Relation of body composition, fat mass, and serumlipids to osteoporotic fractures and bone mineral density in Chinesemen and women. Am J Clin Nutr. 2006;83:146-154.
  6. Parhami F, Basseri B, Hwang J, Tintut Y, Demer L. High-density lipoprotein regulates calcification of vascular cells. Circ Res. 2002;91(7):570-576. doi: 10.1161/01.res.0000036607.05037.
  7. Parhami F, Garfinkel A, Demer L. Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol. 2000;20(11):2346-2348. doi: 10.1016/s0952-3278(03)00060-7.
  8. Parhami F, Morrow A, Balucan J, Leitinger N, Watson A, Tintut Y, Berliner J, Demer L. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 1997;17(4):680-687. doi: 10.1161/01.atv.17.4.680.
  9. Tintut Y, Morony S, Demer L. Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol. 2004;24(2):6-10. doi: 10.1161/01.atv.0000112023.62695.7f.
  10. Jeon Y, Lee J, Kim SS, Kim B, Kim SJ, Kim YK, Kim IJ. Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women. Endocr J. 2011;58:87-93. doi: 10.1507/endocrj.k10e-297.
  11. Jeong I, Cho S, Kim S, Choi H, Park K, Kim S, Lee H, Cho S, Oh B, Shin C. Lipid profiles and bone mineral density in pre- and postmenopausal women in Korea. Calcif Tissue Int. 2010;87:507-512. doi: 10.1007/s00223-010-9427-3.
  12. Choi H, Kim K, Kim K, Hur N, Rhee Y, Han D. Relationship between visceral adiposity and bone mineral density in Korean adults. Calcif Tissue Int. 2010;87:218-225. doi: 10.1007/s00223-010-9398-4.
  13. Park K, Kim S, Moon E. Association between bone mineral density and metabolic syndrome in postmenopausal. Korean women. Gynecol Obstet Invest. 2010;69:145-152. doi: 10.1507/endocrj.k09e-228.
  14. Hernandez J, Olmos J, Ramos C, Martinez J, de Juan J, Valero C, Nan D, Gonzalez-Maclas J. Serum lipids and bone metabolism in Spanish men: the Camargo cohort study. Endocr J. 2010;57:51-60. doi: 10.1507/endocrj.k09e-228.
  15. Buizert P, van Schoor N, Lips P, Deeg D, Eekhoff E. Lipid levels: a link between cardiovascular disease and osteoporosis? J Bone Miner Res. 2009;24:1103-1109. doi: 10.1359/jbmr.081262.
  16. Sivas F, Alemdaroglu E, Elverici E, Kulug T, Ozoran K. Serum lipid profile: its relationship with osteoporotic vertebrae fractures and bone mineral density in Turkish postmenopausal women. Rheumatol Int. 2008;29:885-890. doi: 10.1007/s00296-008-0784-4.
  17. Makovey J, Chen J, Hayward C, Williams F, Sambrook P. Association between serum cholesterol and bone mineral density. Bone. 2009;44:2080213. doi: 10.1016/j.bone.2008.09.020.
  18. D′Amelio P, Di Bella S, Tamone C, Ravazzoli M, Cristofaro M, Di Stefano M, Isaia G. HDL cholesterol and bone mineral density in normal-weight postmenopausal women: is there any possible association? Panminerva Med. 2008;50:89-96.
  19. Dennison E, Syddall H, Aihie Sayer A, Martin H, Cooper C. Lipid profile, obesity and bone mineral density: the Hertfordshire Cohort Study. QJM. 2007;100:297-303. doi: 10.1093/qjmed/hcm023.
  20. Bagger YZ, Rasmussen HB, Alexandersen P, Werge T, Christiansen C, Tanko LB. Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se? Osteoporos Int. 2007;18:505-512.
  21. Cui L, Shin M, Chung E, Lee Y, Kweon S, Park K, Choi J. Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea. Osteoporos Int. 2005;16:1975-1981. doi: 10.1007/s00198-005-1977-2.
  22. Solomon DH, Avorn J, Canning CF, Wang PS. Lipid levels and bone mineral density. Am J Med. 2005;118:1414. doi: 10.1016/j.amjmed.2005.07.03.
  23. Adami S, Braga V, Zamboni M, Gatti D, Rossini M, Bakri J et al. Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int. 004;74:136-142. doi: 10.1007/s00223-003-0050-4.
  24. Wu L, Yang T, Kuo S, Hsiao C, Hung Y, Hsieh C, Tseng H, Hsieh A, Chen T, Chang J, Pei D. Correlation between bone mineral density and plasma lipids in Taiwan. Endocr Res. 2003;29(3): 317-325. doi: 10.1081/erc-120025039.
  25. Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, Chihara K. Plasma lipids and osteoporosis in postmenopausal women. Endocr J. 2002;49:211-217. doi: 10.1081/erc-120025039.
  26. Lidfeldt J, Holmdahl L, Samsioe G, Nerbrand C, Nyberg P, Schersten B, Agardh C. The influence of hormonal status and features of the metabolic syndrome on bone density: a population-based study of Swedish women aged 50 to 59 years. The women’s health in the Lund area study. Metabolism. 2002;51:267-270. doi: 10.1053/meta.2002.300001.
  27. Tanko L, Bagger Y, Nielsen S, Christiansen C. Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? Bone. 2003;32(1):8-14. doi: 10.1016/s8756-3282(02)00918-3.
  28. Broulik P, Kapitola J. Interrelations between body weight, cigarette smoking and spine mineral density in osteoporotic Czech women. Endocr Regul. 1993;27(2):57-60.
  29. Poli A, Bruschi F, Cesana B, Rossi M, Paoletti R, Crosignani P. Plasma low-density lipoprotein cholesterol and bone mass densitometry in postmenopausal women. Obstet Gynecol. 2003;102(5 Pt 1):922-926. doi: 10.1016/j.obstetgynecol.2003.07.004.
  30. Brownbill R, Ilich J. Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women. J Women’s Health (Larchmt). 2006;15(3):261-270. doi: 10.1089/jwh.2006.15.261.
  31. Samelson E, Cupples L, Hannan M et al. Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham Osteoporosis Study. Bone. 2004;34(3):557-561. doi: 10.1016/j.bone.2003.11.024.
  32. Wang P, Solomon D, Mogun H et al. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA. 2000;283(24):3211. doi: 10.1001/jama.283.24.3211.
  33. Adami S, Braga V, Guidi G, Gatti D, Gerardi D, Fracassi E. Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol. J Bone Miner Res. 2000;15(3):599-604. doi: 10.1359/jbmr.2000.15.3.599.
  34. Rossouw J. Hormone replacement therapy and cardiovascular disease. Curr Opin Lipidol. 1999;10:429-434. doi: 10.1097/00041433-199910000-00007.
  35. Zabaglia S, Pedro O, Pinto Neto A, Guarisi T, Paiva L, Lane E. Anexploratory study of the association between lipid profile and bone mineral density in menopausal women in a Campinas reference hospital. Cad Saude Publica. 1998;14:779-786.
  36. Птичкина П.А., Скрипникова И.А., Абирова Э.С., Косматова О.В., Мурашко Л.М., Выгодин В.А., Жезлова А.В. Липидный профиль и состав тела у женщин в постменопаузе. Профилактическая медицина. 2012;15(6):65-68.
  37. D′Amelio P, Pescarmona G, Gariboldi A, Isaia G. High density lipoproteins (HDL) in women with postmenopausal osteoporosis: a preliminary study. Menopause. 2001;8(6):429-432. doi: 10.1097/00042192-200111000-00008.
  38. Ackert-Bicknell С. HDL cholesterol and bone mineral density: Is there a genetic link? Bone. 2012;50:525-533. doi: 10.1016/j.bone.2011.07.002.
  39. Brodeur R, Brissette L, Falstrault L, Moreau R. HDL3 reduces the association and modulates the metabolism of oxidized LDL by osteoblastic cells: a protection against cell death. J Cell Biochem. 2008;105(6):1374-1385. doi: 10.1002/jcb.21938.
  40. Cauley JA, Zmuda JM,Yaffe K, Kuller LH, Ferrell RE, Wisniewski SR, Cummings SR. Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk. The study of osteoporotic fractures. J Bone MinerRes. 1999;14:1175-1181. doi: 10.1359/jbmr.1999.14.7.1175.
  41. Stevenson J, Crook D, Godsland I. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis. 1993;98:83-90. doi: 10.1016/0021-9150(93)90225-j.
  42. Перова Н.В., Метельская В.А. Метаболические нарушения в патогенезе атеросклероза и методы их коррекции. М.; 2008.

Copyright (c) 2016 Skripnikova I.A., Abirova E.S., Alyasova P.A., Alikhanova N.A., Khudyakov M.B., Vygodin V.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies